Tumor Board on Metaplastic Breast Cancer

Navigating the complexities of metaplastic breast cancer and determining the most effective treatments can be challenging for even the most experienced oncologists. Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) facilitates a discussion with experts from MSK (New York) and Max Healthcare (India) about the unique clinical scenarios, challenges, and global perspectives associated with metaplastic breast cancer. This series will enhance the understanding of this rare and aggressive cancer type, providing insights into precision therapies and emerging trends in treatment.